DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma. Here, DNAJB1 is linked to fibrolamellar hepatocellular carcinoma.